The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArmadale Capital Regulatory News (ACP)

Share Price Information for Armadale Capital (ACP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.725
Bid: 0.70
Ask: 0.75
Change: 0.00 (0.00%)
Spread: 0.05 (7.143%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.725
ACP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Subscription and Investment Portfolio Update

28 May 2021 15:45

RNS Number : 2575A
Armadale Capital PLC
28 May 2021
 

 

Armadale Capital Plc / Index: AIM / Epic: ACP / Sector: Investment Company

 

Date 28 May 2021

 

Armadale Capital Plc ('Armadale' or 'the Company')

 

 Subscription and Investment Portfolio Update

Armadale Capital plc (LON: ACP), the AIM quoted investment group focused on natural resource projects in Africa is pleased to announce that is has raised £850,000 via a private subscription with certain existing high-net worth shareholders in the Company (the 'Subscription').

As part of the Subscription, 18,888,889 new ordinary shares ('Ordinary Shares') ('Subscription Shares') in the Company will be issued at a price of 4.5 pence per Ordinary Share which was the mid-market price on 27 May 2021, being the last trading day immediately preceding this announcement. In addition, Subscribers will also receive one warrant for each Ordinary Share subscribed for, exercisable at a price of 7.00 pence and expiring on the three-year anniversary of the date of issue (the 'Warrants'). In aggregate, 18,888,889 Warrants will be issued alongside this Subscription.

The Subscription was carried out directly with investors and there were no broker fees paid.

Use of Proceeds

Following the delivery of an extremely compelling feasibility study for the Mahenge Liandu graphite project in Tanzania, these funds will strengthen the Company's balance sheet as it seeks to progress development finance workstreams ahead of construction; they will also enable Armadale to further progress essential Front End Engineering Design studies being carried out by the Chinese group Xinhai Mineral EPC and also be used for general working capital purposes.

Investment Portfolio Update

In addition to driving development at Mahenge Liandu graphite project, Armadale continues to operate as a diversified investing company investing in natural resource projects in Africa and to this end it has maintained a small portfolio of quoted investments, principally in resource companies where the Directors believe there are opportunities for capital gain.

With regard to these investments, Armadale wishes to inform investors that recently there have been significant gains in the Company's listed portfolio and that the current value of listed investments is approximately CAD 1.4 million.

The Company continues to keep its portfolio under review. The Company's strategy with its quoted portfolio is to gain exposure in projects that have the potential to create short to medium term returns for the Company as well as diversify the Company's exposure to a broader range of commodities while being able to enter and exit the position with minimal cost and time.

Armadale Chairman, Nick Johansen, commented: 

"It is fantastic to have such strong inward demand by investors and to be able to conduct this Subscription without a discount to the prevailing share price - a testament indeed to the compelling economics of Mahenge and a recognition of the way Armadale has significantly derisked the Mahenge project and driven significant shareholder value since previous fundraises more so in recent months with the approval of the Environmental and Social Impact Assessment which is the final necessary step in our Mining Licence application process. We have also delivered a successful first phase of our FEED studies testwork thus confirming our process flowsheet as per our Definitive Feasibility Study and helping to ratify the exceptional economics of the project. These funds will also help to strengthen the Company's existing balance sheet as we look to further potential progress development finance options with the number of finance partner / provider candidates with whom we are currently engaged.

We are also delighted to report that the Company's quoted investment portfolio has done particularly well as of late and with a present value of circa CAD 1.4 million, has delivered healthy returns for shareholders. The Company will continue to review opportunities as appropriate; investors should note that profits and capital from listed investments may at some stage be used to progress development at our Mahange graphite project. We look forward to updating the market regularly."

Total Voting Rights and Share Admission

Following Admission, the Company will have 501,167,889 Ordinary Shares of 0.1 pence each in issue with no shares held in treasury, each with one vote per share. Therefore, the total number of voting rights in the Company will be 501,167,889. This figure may be used by shareholders in the Company as the denominator for calculations to determine if they have a notifiable interest in the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules, or if such interest has changed.

The Subscription is conditional upon, inter alia, admission ('Admission') of the Subscription Shares to trading (which will be issued and settled in CREST to the extent possible) on AIM. Application will be made for Admission, which is expected to occur on or around 8.00 a.m. on 04 June 2021.

 

 

**ENDS**

 

Enquiries:

 

Armadale Capital Plc

Nick Johansen, Non-Executive Director

Tim Jones, Company Secretary

 

 

 

+44 (0) 20 7236 1177

Nomad and broker: finnCap Ltd

Christopher Raggett / Teddy Whiley

 

+44 (0) 20 7220 0500

 

Notes

Armadale's wholly-owned Mahenge Liandu Graphite Project is located in a highly prospective region, with a high-grade JORC compliant indicated and inferred mineral resource estimate announced February 2018 - 59.5Mt at 9.8% TGC. This includes 11.5Mt @ 10.5% Measured 32.Mt Indicted at 9.6% and 15.9Mt at 9.8% TGC, making it one of the largest high-grade resources in Tanzania.

The work to date has demonstrated the Project's potential as a commercially viable deposit, with significant tonnage, high-grade coarse flake and near surface mineralisation (implying a low strip ratio) contained within one contiguous ore body.

The Company's updated Definitive Feasibility Study (June 2020) confirmed Mahenge as a long-life low-cost graphite project with a US$430m NPV and IRR of 91% based on a two-stage expansion strategy comprising:

· Stage One - processing plant and infrastructure at a nominal design basis rate of 0.4-0.5 Mt/pa to produce a nominal 60,000t/pa graphite concentrate in the first three years of production

· Stage Two - a second 0.5 Mt/y plant and associated additional infrastructure doubling throughput to 1 Mt/y from Year 5 of operation

The DFS shows that Armadale can be a significant low-cost supplier to the graphite industry with the potential to generate pre-tax cashflows of US$985m over an initial 15 year mine-life and scope for further improvement as this utilises just 25% of the current resource, which remains open in multiple directions.

Projected timeline to first production is expected to be approximately 10-12 months from the start of construction and the capital cost estimate for Stage 1 is US$39.7m, which includes a contingency of U$S4.1m or 15% of total direct capital cost, with a 1.6 year payback for Stage 1 (after tax) based on an average sales price of US$1,112/t. Stage 2 expansion is expected to be funded from cashflow.

More information can be found on the website www.armadalecapitalplc.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFSSEVITFIL
Date   Source Headline
24th Apr 20248:30 amRNSProposed Investment, Subscription & Board Changes
27th Feb 20242:45 pmRNSMahenge Project Update
19th Dec 202311:15 amRNSBlock listing Interim Review
29th Sep 20237:00 amRNSHalf-year Report
20th Jun 202310:38 amRNSResult of AGM
19th Jun 20237:00 amRNSBlock listing Interim Review
12th May 20237:00 amRNSFinal Results and Notice of AGM
13th Feb 20239:00 amRNSMahenge Project Update
19th Dec 20227:00 amRNSBlock listing Interim Review
29th Sep 20227:00 amRNSHalf-year Report
20th Jun 202210:45 amRNSResult of AGM
17th Jun 20223:30 pmRNSBlock listing Interim Review
23rd May 20227:00 amRNSFinal Results and Notice of AGM
3rd May 20227:00 amRNSIssue of Equity Under Block Admission Arrangements
1st Apr 20227:00 amRNSIssue of Equity Under Block Admission Arrangements
17th Mar 20223:20 pmRNSHolding(s) in Company
11th Mar 20222:45 pmRNSDirector/PDMR Shareholding and TVR
8th Feb 20228:15 amRNSAdvancing Mining Lease and Expanded Footprint
17th Dec 20217:00 amRNSBlock listing Interim Review
15th Dec 20219:30 amRNSManagement Team Enhanced With Key Appointment
1st Dec 20217:00 amRNSIssue of Equity Under Block Admission Arrangements
1st Nov 20217:00 amRNSIssue of Equity Under Block Admission Arrangements
1st Oct 20217:00 amRNSIssue of equity under block admission arrangements
29th Sep 20217:00 amRNSHalf-year Report
3rd Sep 20219:00 amRNSMahenge Mining Licence Granted
31st Aug 20217:00 amRNSNotification of Changes in Major Holdings
6th Aug 20211:25 pmRNSConversion of Loan Notes and Director Shareholding
28th Jun 202112:40 pmRNSBlock Admission & TVR
28th Jun 202112:18 pmRNSAGM Statement
17th Jun 20217:00 amRNSBlock listing Interim Review
28th May 20213:45 pmRNSSubscription and Investment Portfolio Update
28th May 20213:18 pmRNSFinal Results And Notice of AGM
22nd Apr 202110:00 amRNSCompletion of Test Work Program
12th Apr 20219:20 amRNSChange of Adviser
30th Mar 20219:58 amRNSESIA Approval from NEMC of Tanzania
24th Mar 20217:35 amRNSBoard Change
8th Mar 202112:36 pmRNSNotification of Changes in Major Holdings
17th Feb 20214:41 pmRNSSecond Price Monitoring Extn
17th Feb 20214:35 pmRNSPrice Monitoring Extension
10th Feb 202111:00 amRNSArmadale Reports Successful Chinese EPC Test-Work
11th Jan 202111:00 amRNSCSIRO Graphite Test Work Results
17th Dec 20207:00 amRNSBlock listing Interim Review
24th Nov 202012:03 pmRNSTest-Work Commenced with Leading EPC Contractor
20th Nov 20204:41 pmRNSSecond Price Monitoring Extn
20th Nov 20204:36 pmRNSPrice Monitoring Extension
13th Oct 202010:00 amBUSMahenge Graphite Project Update
6th Oct 20204:41 pmRNSSecond Price Monitoring Extn
6th Oct 20204:36 pmRNSPrice Monitoring Extension
29th Sep 20208:46 amBUSHalf-year Report
8th Sep 202012:45 pmBUSEnvironmental and Social Impact Assessment Submitted

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.